Ensysce Biosciences (ENSC) Payables (2017 - 2025)
Ensysce Biosciences' Payables was $3.57 million in Q4 2025, up 115.5% from $1.66 million a year earlier and up 319.9% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Payables (2017 - 2025) Analysis & Trends
From Q4 2017 onward, Ensysce Biosciences has reported Payables for 33 quarters.
- Payables shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In earlier years, Payables was $1.66 million in FY2024 (-40.6%), $2.79 million in FY2023 (-61.3%), $7.21 million in FY2022 (-44.7%) and $13.05 million in FY2021 (+118.6%).
- The Q4 2025 figure marks the highest quarterly Payables since Q4 2022.
- Compared with a year earlier, Payables was higher in three of the last eight quarters, with growth averaging 7.0%.
- The best year-over-year quarter for Payables over five years was Q3 2021 (growth of 901.5%); the worst was Q1 2021 (a decline of 90.9%).
- Per Business Quant data, ENSC's Payables in the three quarters before Q4 2025 was $851,160 (Q3 2025), $1.47 million (Q2 2025) and $872,678 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Ensysce Biosciences | 1.30 Mn | -9.94 Mn | - | 3.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.57 Mn |
| Sep 30, 2025 | 851,160.00 |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 872,678.00 |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 936,434.00 |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 8.84 Mn |
| Jun 30, 2022 | 5.57 Mn |
| Mar 31, 2022 | 7.03 Mn |
| Dec 31, 2021 | 13.05 Mn |
| Sep 30, 2021 | 3.27 Mn |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 319,180.00 |
API Access
Ensysce Biosciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();